To control bacterial and parasitic diseases, antibiotics and drugs were used indiscriminately. Antibiotic application had been an effective strategy in the beginning, but the residuals remaining in the rearing environment for long periods of time became a big challenge (Lakshmi et al. 2013) .
The indiscriminate use resulted in the emergence of antibiotic-resistant bacteria in aquaculture environments and increases the antibiotic resistance in fish pathogens (Verschuere et al. 2000) . Therefore alternative means of disease management is imperative. In this present scenario, vaccination would be the best alternative to combat bacterial and viral disease for the sustainable aquaculture.
To date vaccines are available for most aquaculture fish species; most are targeting bacterial pathogens and only a few are raised against viruses. Depending on the age and size of the fish, commercial vaccines are administered either orally (by mixing with the feed), by immersion (dip or bath) or by injection through the intraperitoneal (i.p.) or intramuscular (i.m.) route (Embregts and Forlenza 2016) . Vaccine by injection route although very effective in terms of immune response and long term protection but it has some side effects including tissue inflammation, adhesion and necrosis. On the other hand immersion vaccination required high production costs. Oral vaccines are an attractive alternative to reduce the stress on the fish during immunization (Gudding et al. 1999) . Due to the ease, simplicity and practical applicability, oral vaccination became the choice of antigen delivery. However, attempts to orally vaccinate against different bacterial diseases have either yielded mild and shortlived or inadequate responses. One of the important factors for the inconsistency and poor response to oral vaccination is the digestive degradation of antigens in the foregut, before the vaccine reaches immune-responsive areas in the hind-gut and other lymphoid organs (Johnson and Amend 1983; Rombout et al. 1985) .
To protect oral antigens from the gastric destruction several strategies were evaluated, such as encapsulated antigen microspheres, enteric coated vaccine and bioencapsulation of vaccine in live feed, these are complex, costly and impractical method (Siriyappagouder el al. 2014) . In this respect biofilm vaccines would be the best alternative way for oral route of vaccination. Biofilm cell produce adhesive exopolymeric substance, which is called glycocalyx, offer protection to antigen from gastric destruction.
Over the 20 years, the vaccine research has been oriented towards safer and more effective vaccine preparation from a normal inactivated bacterial vaccine to the biofilm vaccine (Azad et al. 1997) . Various researches conducted in the preparation of biofilm of Aeromonas hydrophila and Vibrio alginolyticus and its use as oral vaccine under the direct supervision of renowned Indian scientist and ICAR (Indian Council of Agriculture Research) Emeritus Professor Dr. K.M Shankar at the Laboratory of Aquatic Health Management, College of Fisheries, Mangalore have shown promising outcome in teleost fishes like catla, rohu, common carp (Azad et.al. 1997 (Azad et.al. , 1999 (Azad et.al. , 2000 , catfishes like C. batrachus (Nayak et. al. 2004 ), tiger shrimp (P. monodon, Krupesh et. al. 2010) and C. striatus (Siriyappagouder et al. 2014 ).
The hypothesis was proposed and substantiated first by Azad et al. (1997 Azad et al. ( , 1999 . They isolated A. hydrophila, later developed to form biofilm on chitin flakes and successfully utilized it as oral vaccine in catla, rohu and common carp. Biofilm vaccinated carps had significantly higher antibody titer and protection than free cell (FC) vaccinated fishes. In subsequent attempt, Azad et al. (1999) standardized the dosage and duration for biofilm oral vaccination. A 20 day immunization with 10 10 CFU/g fish/d proved to be ideal for oral vaccination.
Biofilm of A. hydrophila was successfully evaluated for oral vaccination of walking catfish (C. batrachus) (Nayak et al. 2004 ) . Fish were fed with biofilm (BF) or free cells (FC) of A. hydrophila for 20 days, and monitored for serum antibody production up to 60 days post-vaccination. They found significantly higher antibody titer and relative per cent survival (RPS) in catfish fed with BF vaccine compared to that with FC following challenge test. Immune response in juvenile tiger shrimp, P. monodon fed with biofilm (BF) and free cells (FC) of V. alginolyticus was studied by Krupesh et al. 2010 . Among the different doses of BF of V. alginolyticus tested, 10 9 cfu/g shrimp/day for two weeks could elicit higher immune response. BF fed shrimp were more resistant to injection challenge with V. alginolyticus and white spot syndrome virus (WSSV) with significantly higher RPS compared to that with FC fed and control shrimp. Another study by Siriyappagouder et al. 2014, with C. striatus , a carnivorous fish model, fed with biofilm (BF) and free cell (FC) of A. hydrophila with the same dose and duration of Nayak et al. 2004 . They observed BF vaccinated fish upon challenge with A. hydrophila at 10 9 cfu/ml had significantly higher relative per cent survival (88) than that of FC (29.6).
Biofilm cells proved to be effective as oral vaccination of fin and shellfishes. Production of biofilm vaccines and its efficacy has been proven in institutional research experiments, now it is high time to produce on a large commercial scale to address the infectious diseases. It can be considered as simple, cheap and ideal oral vaccination technique for bulk administration.
